Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 100% increase over the number of companies cited in the previous quarter.
The citations in the county include:
- Separate or defined areas to prevent contamination or mix-ups are deficient regarding the manufacturing and processing operations.
- Specific identification tests are not conducted on components that have been accepted based on the supplier's report of analysis.
- You did not conduct and document your hazard analysis.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Athea Laboratories, Inc. | Drugs | 12/20/2023 | Mfg / Processing Operations Area |
Athea Laboratories, Inc. | Drugs | 12/20/2023 | Component identification test |
Colectivo Coffee Roasters, Inc. | Food and Cosmetics | 11/07/2023 | Hazard analysis - Conducted |
Colectivo Coffee Roasters, Inc. | Food and Cosmetics | 11/07/2023 | Supply-chain program - Establish |